img

Global Monkeypox Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Monkeypox Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Monkeypox (mpox) is a viral infection that spreads from animals to humans, hence it is called a zoonotic infection. The recent outbreak of mpox on May 6, 2022. The human mpox virus was initially identified in 1970 in the Democratic Republic of Congo. The source of the virus is unknown; however, the first six monkeypox cases were found in the UK. Fever, swelling in the lymph nodes, rashes on the skin, chills, muscle fatigue, headache, backache, and respiratory symptoms such as sore throat, cough, and congestion are the common symptoms of monkeypox infection. The virus is transmitted sexually or through touch. The disease has claimed the lives of some people. People with weak immunity, breastfeeding mothers, women during pregnancy, children below the age of 10 years, and people having prolonged exposure to the infected animal are susceptible to the viral infection.
Monkeypox Treatment report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Monkeypox Treatment market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Hospital Pharmacy and Online Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Monkeypox Treatment industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Monkeypox Treatment key companies include Bavarian Nordic, Chimerix, Inc., CIDIC Company Limited, Emcure Pharmaceuticals, Emergent, Gilead Sciences Inc., Hetero Drugs Limited, Jinan Jinda Pharmaceutical Chemistry Co. Ltd. and Mylan N.V., etc. Bavarian Nordic, Chimerix, Inc., CIDIC Company Limited are top 3 players and held % share in total in 2022.
Monkeypox Treatment can be divided into Oral and Injectable, etc. Oral is the mainstream product in the market, accounting for % share globally in 2022.
Monkeypox Treatment is widely used in various fields, such as Hospital Pharmacy, Online Pharmacy and Retail Pharmacy,, etc. Hospital Pharmacy provides greatest supports to the Monkeypox Treatment industry development. In 2022, global % share of Monkeypox Treatment went into Hospital Pharmacy filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Monkeypox Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Bavarian Nordic
Chimerix, Inc.
CIDIC Company Limited
Emcure Pharmaceuticals
Emergent
Gilead Sciences Inc.
Hetero Drugs Limited
Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
Mylan N.V.
Olon S.p.A.
Piramal Pharma Solutions
SIGA Technologies Inc.
Sonofi SA
Teva Pharmaceutical Industries Limited
Segment by Type
Oral
Injectable

Segment by Application


Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Monkeypox Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Monkeypox Treatment introduction, etc. Monkeypox Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Monkeypox Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Monkeypox Treatment
1.1 Monkeypox Treatment Market Overview
1.1.1 Monkeypox Treatment Product Scope
1.1.2 Monkeypox Treatment Market Status and Outlook
1.2 Global Monkeypox Treatment Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Monkeypox Treatment Market Size by Region (2018-2033)
1.4 Global Monkeypox Treatment Historic Market Size by Region (2018-2023)
1.5 Global Monkeypox Treatment Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Monkeypox Treatment Market Size (2018-2033)
1.6.1 North America Monkeypox Treatment Market Size (2018-2033)
1.6.2 Europe Monkeypox Treatment Market Size (2018-2033)
1.6.3 Asia-Pacific Monkeypox Treatment Market Size (2018-2033)
1.6.4 Latin America Monkeypox Treatment Market Size (2018-2033)
1.6.5 Middle East & Africa Monkeypox Treatment Market Size (2018-2033)
2 Monkeypox Treatment Market by Type
2.1 Introduction
2.1.1 Oral
2.1.2 Injectable
2.2 Global Monkeypox Treatment Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Monkeypox Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Monkeypox Treatment Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Monkeypox Treatment Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Monkeypox Treatment Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Monkeypox Treatment Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Monkeypox Treatment Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Monkeypox Treatment Revenue Breakdown by Type (2018-2033)
3 Monkeypox Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacy
3.1.2 Online Pharmacy
3.1.3 Retail Pharmacy
3.2 Global Monkeypox Treatment Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Monkeypox Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Monkeypox Treatment Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Monkeypox Treatment Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Monkeypox Treatment Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Monkeypox Treatment Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Monkeypox Treatment Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Monkeypox Treatment Revenue Breakdown by Application (2018-2033)
4 Monkeypox Treatment Competition Analysis by Players
4.1 Global Monkeypox Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Monkeypox Treatment as of 2022)
4.3 Date of Key Players Enter into Monkeypox Treatment Market
4.4 Global Top Players Monkeypox Treatment Headquarters and Area Served
4.5 Key Players Monkeypox Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Monkeypox Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bavarian Nordic
5.1.1 Bavarian Nordic Profile
5.1.2 Bavarian Nordic Main Business
5.1.3 Bavarian Nordic Monkeypox Treatment Products, Services and Solutions
5.1.4 Bavarian Nordic Monkeypox Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Bavarian Nordic Recent Developments
5.2 Chimerix, Inc.
5.2.1 Chimerix, Inc. Profile
5.2.2 Chimerix, Inc. Main Business
5.2.3 Chimerix, Inc. Monkeypox Treatment Products, Services and Solutions
5.2.4 Chimerix, Inc. Monkeypox Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Chimerix, Inc. Recent Developments
5.3 CIDIC Company Limited
5.3.1 CIDIC Company Limited Profile
5.3.2 CIDIC Company Limited Main Business
5.3.3 CIDIC Company Limited Monkeypox Treatment Products, Services and Solutions
5.3.4 CIDIC Company Limited Monkeypox Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Emcure Pharmaceuticals Recent Developments
5.4 Emcure Pharmaceuticals
5.4.1 Emcure Pharmaceuticals Profile
5.4.2 Emcure Pharmaceuticals Main Business
5.4.3 Emcure Pharmaceuticals Monkeypox Treatment Products, Services and Solutions
5.4.4 Emcure Pharmaceuticals Monkeypox Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Emcure Pharmaceuticals Recent Developments
5.5 Emergent
5.5.1 Emergent Profile
5.5.2 Emergent Main Business
5.5.3 Emergent Monkeypox Treatment Products, Services and Solutions
5.5.4 Emergent Monkeypox Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Emergent Recent Developments
5.6 Gilead Sciences Inc.
5.6.1 Gilead Sciences Inc. Profile
5.6.2 Gilead Sciences Inc. Main Business
5.6.3 Gilead Sciences Inc. Monkeypox Treatment Products, Services and Solutions
5.6.4 Gilead Sciences Inc. Monkeypox Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Gilead Sciences Inc. Recent Developments
5.7 Hetero Drugs Limited
5.7.1 Hetero Drugs Limited Profile
5.7.2 Hetero Drugs Limited Main Business
5.7.3 Hetero Drugs Limited Monkeypox Treatment Products, Services and Solutions
5.7.4 Hetero Drugs Limited Monkeypox Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Hetero Drugs Limited Recent Developments
5.8 Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
5.8.1 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Profile
5.8.2 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Main Business
5.8.3 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Products, Services and Solutions
5.8.4 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Recent Developments
5.9 Mylan N.V.
5.9.1 Mylan N.V. Profile
5.9.2 Mylan N.V. Main Business
5.9.3 Mylan N.V. Monkeypox Treatment Products, Services and Solutions
5.9.4 Mylan N.V. Monkeypox Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Mylan N.V. Recent Developments
5.10 Olon S.p.A.
5.10.1 Olon S.p.A. Profile
5.10.2 Olon S.p.A. Main Business
5.10.3 Olon S.p.A. Monkeypox Treatment Products, Services and Solutions
5.10.4 Olon S.p.A. Monkeypox Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Olon S.p.A. Recent Developments
5.11 Piramal Pharma Solutions
5.11.1 Piramal Pharma Solutions Profile
5.11.2 Piramal Pharma Solutions Main Business
5.11.3 Piramal Pharma Solutions Monkeypox Treatment Products, Services and Solutions
5.11.4 Piramal Pharma Solutions Monkeypox Treatment Revenue (US$ Million) & (2018-2023)
5.11.5 Piramal Pharma Solutions Recent Developments
5.12 SIGA Technologies Inc.
5.12.1 SIGA Technologies Inc. Profile
5.12.2 SIGA Technologies Inc. Main Business
5.12.3 SIGA Technologies Inc. Monkeypox Treatment Products, Services and Solutions
5.12.4 SIGA Technologies Inc. Monkeypox Treatment Revenue (US$ Million) & (2018-2023)
5.12.5 SIGA Technologies Inc. Recent Developments
5.13 Sonofi SA
5.13.1 Sonofi SA Profile
5.13.2 Sonofi SA Main Business
5.13.3 Sonofi SA Monkeypox Treatment Products, Services and Solutions
5.13.4 Sonofi SA Monkeypox Treatment Revenue (US$ Million) & (2018-2023)
5.13.5 Sonofi SA Recent Developments
5.14 Teva Pharmaceutical Industries Limited
5.14.1 Teva Pharmaceutical Industries Limited Profile
5.14.2 Teva Pharmaceutical Industries Limited Main Business
5.14.3 Teva Pharmaceutical Industries Limited Monkeypox Treatment Products, Services and Solutions
5.14.4 Teva Pharmaceutical Industries Limited Monkeypox Treatment Revenue (US$ Million) & (2018-2023)
5.14.5 Teva Pharmaceutical Industries Limited Recent Developments
6 North America
6.1 North America Monkeypox Treatment Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Monkeypox Treatment Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Monkeypox Treatment Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Monkeypox Treatment Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Monkeypox Treatment Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Monkeypox Treatment Market Dynamics
11.1 Monkeypox Treatment Industry Trends
11.2 Monkeypox Treatment Market Drivers
11.3 Monkeypox Treatment Market Challenges
11.4 Monkeypox Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Monkeypox Treatment Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Monkeypox Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Monkeypox Treatment Market Size Share by Region (2018-2023)
Table 4. Global Monkeypox Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Monkeypox Treatment Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Monkeypox Treatment Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Monkeypox Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Monkeypox Treatment Revenue Market Share by Type (2018-2023)
Table 9. Global Monkeypox Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Monkeypox Treatment Revenue Market Share by Type (2024-2033)
Table 11. North America Monkeypox Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Monkeypox Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Monkeypox Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Monkeypox Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Monkeypox Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Monkeypox Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Monkeypox Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Monkeypox Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Monkeypox Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Monkeypox Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Monkeypox Treatment Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Monkeypox Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Monkeypox Treatment Revenue Market Share by Application (2018-2023)
Table 24. Global Monkeypox Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Monkeypox Treatment Revenue Market Share by Application (2024-2033)
Table 26. North America Monkeypox Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Monkeypox Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Monkeypox Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Monkeypox Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Monkeypox Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Monkeypox Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Monkeypox Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Monkeypox Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Monkeypox Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Monkeypox Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Monkeypox Treatment Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Monkeypox Treatment Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Monkeypox Treatment as of 2022)
Table 39. Date of Key Players Enter into Monkeypox Treatment Market
Table 40. Global Monkeypox Treatment Key Players Headquarters and Area Served
Table 41. Monkeypox Treatment Product Solution and Service
Table 42. Global Monkeypox Treatment Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Bavarian Nordic Basic Information List
Table 45. Bavarian Nordic Description and Business Overview
Table 46. Bavarian Nordic Monkeypox Treatment Products, Services and Solutions
Table 47. Revenue (US$ Million) in Monkeypox Treatment Business of Bavarian Nordic (2018-2023)
Table 48. Bavarian Nordic Recent Developments
Table 49. Chimerix, Inc. Basic Information List
Table 50. Chimerix, Inc. Description and Business Overview
Table 51. Chimerix, Inc. Monkeypox Treatment Products, Services and Solutions
Table 52. Revenue (US$ Million) in Monkeypox Treatment Business of Chimerix, Inc. (2018-2023)
Table 53. Chimerix, Inc. Recent Developments
Table 54. CIDIC Company Limited Basic Information List
Table 55. CIDIC Company Limited Description and Business Overview
Table 56. CIDIC Company Limited Monkeypox Treatment Products, Services and Solutions
Table 57. Revenue (US$ Million) in Monkeypox Treatment Business of CIDIC Company Limited (2018-2023)
Table 58. CIDIC Company Limited Recent Developments
Table 59. Emcure Pharmaceuticals Basic Information List
Table 60. Emcure Pharmaceuticals Description and Business Overview
Table 61. Emcure Pharmaceuticals Monkeypox Treatment Products, Services and Solutions
Table 62. Revenue (US$ Million) in Monkeypox Treatment Business of Emcure Pharmaceuticals (2018-2023)
Table 63. Emcure Pharmaceuticals Recent Developments
Table 64. Emergent Basic Information List
Table 65. Emergent Description and Business Overview
Table 66. Emergent Monkeypox Treatment Products, Services and Solutions
Table 67. Revenue (US$ Million) in Monkeypox Treatment Business of Emergent (2018-2023)
Table 68. Emergent Recent Developments
Table 69. Gilead Sciences Inc. Basic Information List
Table 70. Gilead Sciences Inc. Description and Business Overview
Table 71. Gilead Sciences Inc. Monkeypox Treatment Products, Services and Solutions
Table 72. Revenue (US$ Million) in Monkeypox Treatment Business of Gilead Sciences Inc. (2018-2023)
Table 73. Gilead Sciences Inc. Recent Developments
Table 74. Hetero Drugs Limited Basic Information List
Table 75. Hetero Drugs Limited Description and Business Overview
Table 76. Hetero Drugs Limited Monkeypox Treatment Products, Services and Solutions
Table 77. Revenue (US$ Million) in Monkeypox Treatment Business of Hetero Drugs Limited (2018-2023)
Table 78. Hetero Drugs Limited Recent Developments
Table 79. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Basic Information List
Table 80. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Description and Business Overview
Table 81. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Products, Services and Solutions
Table 82. Revenue (US$ Million) in Monkeypox Treatment Business of Jinan Jinda Pharmaceutical Chemistry Co. Ltd. (2018-2023)
Table 83. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Recent Developments
Table 84. Mylan N.V. Basic Information List
Table 85. Mylan N.V. Description and Business Overview
Table 86. Mylan N.V. Monkeypox Treatment Products, Services and Solutions
Table 87. Revenue (US$ Million) in Monkeypox Treatment Business of Mylan N.V. (2018-2023)
Table 88. Mylan N.V. Recent Developments
Table 89. Olon S.p.A. Basic Information List
Table 90. Olon S.p.A. Description and Business Overview
Table 91. Olon S.p.A. Monkeypox Treatment Products, Services and Solutions
Table 92. Revenue (US$ Million) in Monkeypox Treatment Business of Olon S.p.A. (2018-2023)
Table 93. Olon S.p.A. Recent Developments
Table 94. Piramal Pharma Solutions Basic Information List
Table 95. Piramal Pharma Solutions Description and Business Overview
Table 96. Piramal Pharma Solutions Monkeypox Treatment Products, Services and Solutions
Table 97. Revenue (US$ Million) in Monkeypox Treatment Business of Piramal Pharma Solutions (2018-2023)
Table 98. Piramal Pharma Solutions Recent Developments
Table 99. SIGA Technologies Inc. Basic Information List
Table 100. SIGA Technologies Inc. Description and Business Overview
Table 101. SIGA Technologies Inc. Monkeypox Treatment Products, Services and Solutions
Table 102. Revenue (US$ Million) in Monkeypox Treatment Business of SIGA Technologies Inc. (2018-2023)
Table 103. SIGA Technologies Inc. Recent Developments
Table 104. Sonofi SA Basic Information List
Table 105. Sonofi SA Description and Business Overview
Table 106. Sonofi SA Monkeypox Treatment Products, Services and Solutions
Table 107. Revenue (US$ Million) in Monkeypox Treatment Business of Sonofi SA (2018-2023)
Table 108. Sonofi SA Recent Developments
Table 109. Teva Pharmaceutical Industries Limited Basic Information List
Table 110. Teva Pharmaceutical Industries Limited Description and Business Overview
Table 111. Teva Pharmaceutical Industries Limited Monkeypox Treatment Products, Services and Solutions
Table 112. Revenue (US$ Million) in Monkeypox Treatment Business of Teva Pharmaceutical Industries Limited (2018-2023)
Table 113. Teva Pharmaceutical Industries Limited Recent Developments
Table 114. North America Monkeypox Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 115. North America Monkeypox Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 116. Europe Monkeypox Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 117. Europe Monkeypox Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 118. Asia-Pacific Monkeypox Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 119. Asia-Pacific Monkeypox Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 120. Asia-Pacific Monkeypox Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 121. Asia-Pacific Monkeypox Treatment Market Share by Region (2018-2023)
Table 122. Asia-Pacific Monkeypox Treatment Market Share by Region (2024-2033)
Table 123. Latin America Monkeypox Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 124. Latin America Monkeypox Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 125. Latin America Monkeypox Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 126. Middle East & Africa Monkeypox Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 127. Middle East & Africa Monkeypox Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 128. Middle East & Africa Monkeypox Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 129. Monkeypox Treatment Market Trends
Table 130. Monkeypox Treatment Market Drivers
Table 131. Monkeypox Treatment Market Challenges
Table 132. Monkeypox Treatment Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monkeypox Treatment Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Monkeypox Treatment Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Monkeypox Treatment Market Share by Regions: 2022 VS 2033
Figure 4. Global Monkeypox Treatment Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Monkeypox Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Monkeypox Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Monkeypox Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Monkeypox Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Monkeypox Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Oral
Figure 11. Global Oral Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Injectable
Figure 13. Global Injectable Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global Monkeypox Treatment Market Size Share by Type: 2022 & 2033
Figure 15. North America Monkeypox Treatment Revenue Market Share by Type (2018-2033)
Figure 16. Europe Monkeypox Treatment Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific Monkeypox Treatment Revenue Market Share by Type (2018-2033)
Figure 18. Latin America Monkeypox Treatment Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa Monkeypox Treatment Revenue Market Share by Type (2018-2033)
Figure 20. Hospital Pharmacy Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Online Pharmacy Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Retail Pharmacy Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Global Monkeypox Treatment Market Size Share by Application: 2022 & 2033
Figure 24. North America Monkeypox Treatment Revenue Market Share by Application (2018-2033)
Figure 25. Europe Monkeypox Treatment Revenue Market Share by Application (2018-2033)
Figure 26. Asia-Pacific Monkeypox Treatment Revenue Market Share by Application (2018-2033)
Figure 27. Latin America Monkeypox Treatment Revenue Market Share by Application (2018-2033)
Figure 28. Middle East and Africa Monkeypox Treatment Revenue Market Share by Application (2018-2033)
Figure 29. Monkeypox Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 30. Global Top 5 and Top 10 Players Monkeypox Treatment Market Share in 2022
Figure 31. North America Monkeypox Treatment Market Share by Country (2018-2033)
Figure 32. United States Monkeypox Treatment Market Size (2018-2033) & (US$ Million)
Figure 33. Canada Monkeypox Treatment Market Size (2018-2033) & (US$ Million)
Figure 34. Germany Monkeypox Treatment Market Size (2018-2033) & (US$ Million)
Figure 35. France Monkeypox Treatment Market Size (2018-2033) & (US$ Million)
Figure 36. U.K. Monkeypox Treatment Market Size (2018-2033) & (US$ Million)
Figure 37. Italy Monkeypox Treatment Market Size (2018-2033) & (US$ Million)
Figure 38. Russia Monkeypox Treatment Market Size (2018-2033) & (US$ Million)
Figure 39. Nordic Countries Monkeypox Treatment Market Size (2018-2033) & (US$ Million)
Figure 40. Asia-Pacific Monkeypox Treatment Market Share by Region (2018-2033)
Figure 41. China Monkeypox Treatment Market Size (2018-2033) & (US$ Million)
Figure 42. Japan Monkeypox Treatment Market Size (2018-2033) & (US$ Million)
Figure 43. South Korea Monkeypox Treatment Market Size (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Monkeypox Treatment Market Size (2018-2033) & (US$ Million)
Figure 45. India Monkeypox Treatment Market Size (2018-2033) & (US$ Million)
Figure 46. Australia Monkeypox Treatment Market Size (2018-2033) & (US$ Million)
Figure 47. Latin America Monkeypox Treatment Market Share by Country (2018-2033)
Figure 48. Mexico Monkeypox Treatment Market Size (2018-2033) & (US$ Million)
Figure 49. Brazil Monkeypox Treatment Market Size (2018-2033) & (US$ Million)
Figure 50. Middle East & Africa Monkeypox Treatment Market Share by Country (2018-2033)
Figure 51. Turkey Monkeypox Treatment Market Size (2018-2033) & (US$ Million)
Figure 52. Saudi Arabia Monkeypox Treatment Market Size (2018-2033) & (US$ Million)
Figure 53. UAE Monkeypox Treatment Market Size (2018-2033) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries